CDC recommends Novavax’s COVID-19 vaccine to be used as primary series option for adolescents

Immediately, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a call memo that Novavax’s COVID-19 vaccine be used as one other major sequence choice for adolescents ages 12 via 17. This advice follows FDA’s authorization to authorize the vaccine for this age group below emergency use.

Novavax’s COVID-19 vaccine, which is offered now, is a vital software within the pandemic and supplies a extra acquainted sort of COVID-19 vaccine expertise for adolescents. Having a number of forms of vaccines provides extra choices and adaptability for the general public, jurisdictions, and vaccine suppliers.

Novavax’s COVID-19 vaccine packages innocent proteins of the COVID-19 virus alongside one other ingredient referred to as an adjuvant that helps the immune system reply to the virus sooner or later. Vaccines-;just like the Novavax COVID-19 vaccine-;that use protein subunit expertise have been used for greater than 30 years in america, starting with the primary licensed hepatitis B vaccine.

Different protein subunit vaccines utilized in america immediately embody these to guard towards influenza and whooping cough (acellular pertussis).